H.B. Fuller Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for H.B. Fuller in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" H.B. Fuller stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FUL, but not buy additional shares or sell existing shares.
View analyst ratings for H.B. Fuller or view top-rated stocks.

Wall Street analysts have given H.B. Fuller a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but H.B. Fuller wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

H.B. Fuller saw a decrease in short interest in August. As of August 13th, there was short interest totaling 1,070,000 shares, a decrease of 18.9% from the July 29th total of 1,320,000 shares. Based on an average trading volume of 327,000 shares, the days-to-cover ratio is presently 3.3 days. Currently, 2.1% of the shares of the stock are short sold.
View H.B. Fuller's Short Interest.

H.B. Fuller is scheduled to release its next quarterly earnings announcement on Wednesday, September 22nd 2021.
View our earnings forecast for H.B. Fuller.

H.B. Fuller will be holding an earnings conference call on Thursday, September 23rd at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "1786575".

H.B. Fuller (NYSE:FUL) issued its earnings results on Tuesday, June, 22nd. The specialty chemicals company reported $0.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.02. The specialty chemicals company had revenue of $827.87 million for the quarter, compared to analysts' expectations of $764.37 million. H.B. Fuller had a trailing twelve-month return on equity of 12.76% and a net margin of 5.33%. The business's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period last year, the firm posted $0.68 EPS.
View H.B. Fuller's earnings history.

H.B. Fuller's stock was trading at $32.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, FUL shares have increased by 85.0% and is now trading at $60.72.
View which stocks have been most impacted by COVID-19.

H.B. Fuller declared a quarterly dividend on Thursday, July 1st. Investors of record on Thursday, July 15th will be paid a dividend of $0.1675 per share on Thursday, July 29th. This represents a $0.67 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend is Wednesday, July 14th.
View H.B. Fuller's dividend history.

H.B. Fuller pays an annual dividend of $0.67 per share and currently has a dividend yield of 1.07%. The dividend payout ratio of H.B. Fuller is 23.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, H.B. Fuller will have a dividend payout ratio of 15.88% next year. This indicates that H.B. Fuller will be able to sustain or increase its dividend.
View H.B. Fuller's dividend history.

4 brokers have issued 12-month price objectives for H.B. Fuller's stock. Their forecasts range from $67.00 to $72.00. On average, they anticipate H.B. Fuller's share price to reach $69.50 in the next year. This suggests a possible upside of 14.5% from the stock's current price.
View analysts' price targets for H.B. Fuller or view top-rated stocks among Wall Street analysts.

87 employees have rated H.B. Fuller CEO James Owens on Glassdoor.com. James Owens has an approval rating of 73% among H.B. Fuller's employees.

Some companies that are related to H.B. Fuller include The Sherwin-Williams (SHW), Ecolab (ECL), International Flavors & Fragrances (IFF), Albemarle (ALB), Celanese (CE), RPM International (RPM), Ashland Global (ASH), W. R. Grace & Co. (GRA), Balchem (BCPC), Quaker Chemical (KWR), Sensient Technologies (SXT), NewMarket (NEU), Stepan (SCL), Valaris (VAL) and Minerals Technologies (MTX).
View all of FUL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other H.B. Fuller investors own include Lowe's Companies (LOW), Medtronic (MDT), The Boeing (BA), Cardinal Health (CAH), Target (TGT), Exxon Mobil (XOM), Abbott Laboratories (ABT), Archer-Daniels-Midland (ADM), Broadcom (AVGO) and Becton, Dickinson and (BDX).

H.B. Fuller trades on the New York Stock Exchange (NYSE) under the ticker symbol "FUL."

H.B. Fuller's stock is owned by a number of retail and institutional investors. Top institutional investors include Cooke & Bieler LP (1.80%), Geode Capital Management LLC (1.64%), Bank of New York Mellon Corp (1.42%), Cramer Rosenthal Mcglynn LLC (0.64%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (0.40%) and Russell Investments Group Ltd. (0.30%). Company insiders that own H.B. Fuller stock include James Owens, Nathan D Weaver, Paula M Cooney, Robert J Martsching, Sant R William Van, Timothy J Keenan, Traci L Jensen and Zhiwei Cai.
View institutional ownership trends for H.B. Fuller.

FUL stock was sold by a variety of institutional investors in the last quarter, including Cooke & Bieler LP, Russell Investments Group Ltd., Credit Suisse AG, California State Teachers Retirement System, Walleye Trading LLC, New York State Common Retirement Fund, Kennedy Capital Management Inc., and Arizona State Retirement System. Company insiders that have sold H.B. Fuller company stock in the last year include James Owens, Nathan D Weaver, Robert J Martsching, Sant R William Van, Timothy J Keenan, and Traci L Jensen.
View insider buying and selling activity for H.B. Fuller or view top insider-selling stocks.

FUL stock was purchased by a variety of institutional investors in the last quarter, including Cramer Rosenthal Mcglynn LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Geode Capital Management LLC, Public Employees Retirement System of Ohio, Susquehanna International Group LLP, Metropolitan Life Insurance Co NY, Bank of New York Mellon Corp, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for H.B. Fuller or or view top insider-buying stocks.

Shares of FUL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FUL stock can currently be purchased for approximately $60.72.

H.B. Fuller has a market capitalization of $3.19 billion and generates $2.79 billion in revenue each year. The specialty chemicals company earns $123.72 million in net income (profit) each year or $2.84 on an earnings per share basis.

H.B. Fuller employs 6,428 workers across the globe.

H.B. Fuller was founded in 1887.

The official website for H.B. Fuller is www.hbfuller.com.

H.B. Fuller is headquartered at 1200 WILLOW LAKE BLVD, ST PAUL MN, 55110.

H.B. Fuller's mailing address is 1200 WILLOW LAKE BLVD, ST PAUL MN, 55110. The specialty chemicals company can be reached via phone at (651) 236-5900 or via email at [email protected]